Abviva Inc (1084966) SEC Filing 10-Q Quarterly report for the period ending Monday, March 31, 2008

Abviva Inc

CIK: 1084966

View differences made from one quarter to another to evaluate Abviva Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abviva Inc.


Assess how Abviva Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abviva Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1084966
Form Type: 10-Q Quarterly Report
Accession Number: 0001365701-08-000020
Submitted to the SEC: Tue May 20 2008 4:23:23 PM EST
Accepted by the SEC: Tue May 20 2008
Period: Monday, March 31, 2008
Industry: Medical Laboratories

External Resources:

Bookmark the Permalink: